AJMC® in the Press, December 2, 2022

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

With ACA subsidies and key CMS payment models ending in 2025, premiums are set to rise, shifting costs to consumers and employers.

Tech Offers Empathy but Digital Divide Looms in Respiratory Health Care

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

Acute respiratory failure. | Image Credit: Selvi - stock.adobe.com .jpeg

Home Health Care Delivery, Outcomes Vary by Payment Model: Rachel A. Prusynski, DPT, PhD

While artificial intelligence showed empathy and precision in respiratory health care, its equitable adoption is paramount to prevent the widening digital divide, as highlighted at the European Respiratory Society Congress 2025.

November 18th 2025

FDA Approves Durvalumab With FLOT Chemotherapy for Resectable Gastric and Gastroesophageal Junction Cancer

Rachel A. Prusynski, DPT, PhD, discusses her study on how payment models affect home health care delivery and patient outcomes.

Listen

FDA approval | Image Credit: Olivier Le Moal - stock.adobe.com

Extreme Heat Raises Mortality Risk for Veterans With Cardiometabolic Disease

This approval makes durvalumab with FLOT chemotherapy the first perioperative immunotherapy for resectable gastric or gastroesophageal junction adenocarcinoma.

US flag in front of camouflage tent | Image credit: F Armstrong Photo – stock.adobe.com

Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers

A case-crossover study found that extreme heat increased mortality between 10% and 18%, with higher risks in vulnerable groups.

Related Content

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

With ACA subsidies and key CMS payment models ending in 2025, premiums are set to rise, shifting costs to consumers and employers.

Tech Offers Empathy but Digital Divide Looms in Respiratory Health Care

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

Home Health Care Delivery, Outcomes Vary by Payment Model: Rachel A. Prusynski, DPT, PhD

November 18th 2025

FDA Approves Durvalumab With FLOT Chemotherapy for Resectable Gastric and Gastroesophageal Junction Cancer

Rachel A. Prusynski, DPT, PhD, discusses her study on how payment models affect home health care delivery and patient outcomes.

Listen

Extreme Heat Raises Mortality Risk for Veterans With Cardiometabolic Disease

This approval makes durvalumab with FLOT chemotherapy the first perioperative immunotherapy for resectable gastric or gastroesophageal junction adenocarcinoma.